Cable Hill Partners, LLC Atara Biotherapeutics, Inc. Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$19.05 - $41.04 $2,476 - $5,335	-130 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $841 - $1,044	-24 Reduced 15.58%	130 $5,000
Q1 2018 Apr 20, 2018	SELL	$18.0 - $48.35 $4,644 - $12,474	-258 Reduced 62.62%	154 $5,000
Q4 2017 Feb 22, 2018	BUY	$13.2 - $18.1 $66 - $90	5 Added 1.23%	412 $7,000
Q3 2017 Oct 27, 2017	SELL	$13.25 - $17.05 $145 - $187	-11 Reduced 2.63%	407 $7,000
Q2 2017 Aug 14, 2017	BUY	N/A	418	418 $6,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $671M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.